Compile Data Set for Download or QSAR
Report error Found 102 Enz. Inhib. hit(s) with all data for entry = 11196
TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598790BDBM598790(US11613546, Example C72)
Affinity DataEC50:  0.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598803BDBM598803(US11613546, Example C86)
Affinity DataEC50:  0.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598802BDBM598802(US11613546, Example C84)
Affinity DataEC50:  0.600nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598748BDBM598748(US11613546, Example C29)
Affinity DataEC50:  0.710nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598791BDBM598791(US11613546, Example C73)
Affinity DataEC50:  0.800nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598816BDBM598816(US11613546, Example C100)
Affinity DataEC50:  0.800nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598783BDBM598783(US11613546, Example C64)
Affinity DataEC50:  0.800nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598770BDBM598770(US11613546, Example C50)
Affinity DataEC50:  0.850nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598792BDBM598792(US11613546, Example C74)
Affinity DataEC50:  0.900nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598750BDBM598750(US11613546, Example C31)
Affinity DataEC50:  0.900nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598736BDBM598736(US11613546, Example C17)
Affinity DataEC50:  0.910nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598743BDBM598743(US11613546, Example C24)
Affinity DataEC50:  0.980nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598794BDBM598794(US11613546, Example C76)
Affinity DataEC50:  1nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598744BDBM598744(US11613546, Example C25 | US11613546, Example C28 ...)
Affinity DataEC50:  1nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598805BDBM598805(US11613546, Example C89)
Affinity DataEC50:  1.10nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598804BDBM598804(US11613546, Example C88)
Affinity DataEC50:  1.10nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598729BDBM598729(US11613546, Example C10 | US11613546, Example C11)
Affinity DataEC50:  1.10nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598776BDBM598776(US11613546, Example C56)
Affinity DataEC50:  1.10nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598738BDBM598738(US11613546, Example C19 | US11613546, Example C20)
Affinity DataEC50:  1.10nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598735BDBM598735(US11613546, Example C16)
Affinity DataEC50:  1.10nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598821BDBM598821(US11613546, Example C108 | US11613546, Example C10...)
Affinity DataEC50:  1.20nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598789BDBM598789(US11613546, Example C70)
Affinity DataEC50:  1.20nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598722BDBM598722(US11613546, Example C2 | US11613546, Example C4)
Affinity DataEC50:  1.20nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598777BDBM598777(US11613546, Example C57)
Affinity DataEC50:  1.20nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598760BDBM598760(US11613546, Example C41 | US11613546, Example C43)
Affinity DataEC50:  1.20nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598763BDBM598763(US11613546, Example C44)
Affinity DataEC50:  1.20nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598768BDBM598768(US11613546, Example C49a | (1S,10R,13R) N-[(2,4-di...)
Affinity DataEC50:  1.20nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598773BDBM598773(US11613546, Example C53)
Affinity DataEC50:  1.30nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598756BDBM598756(US11613546, Example C37 | US11613546, Example C81)
Affinity DataEC50:  1.30nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598771BDBM598771(US11613546, Example C51)
Affinity DataEC50:  1.30nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598746BDBM598746(US11613546, Example C27 | US11613546, Example C66)
Affinity DataEC50:  1.30nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598775BDBM598775(US11613546, Example C55)
Affinity DataEC50:  1.30nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598749BDBM598749(US11613546, Example C30)
Affinity DataEC50:  1.30nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598732BDBM598732(US11613546, Example C13 | US11613546, Example C15)
Affinity DataEC50:  1.30nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598800BDBM598800(US11613546, Example C82)
Affinity DataEC50:  1.30nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598782BDBM598782(US11613546, Example C62)
Affinity DataEC50:  1.40nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598744BDBM598744(US11613546, Example C25 | US11613546, Example C28 ...)
Affinity DataEC50:  1.40nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598818BDBM598818(US11613546, Example C104 | US11613546, Example C10...)
Affinity DataEC50:  1.40nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598753BDBM598753(US11613546, Example C34)
Affinity DataEC50:  1.40nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598746BDBM598746(US11613546, Example C27 | US11613546, Example C66)
Affinity DataEC50:  1.40nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598757BDBM598757(US11613546, Example C38)
Affinity DataEC50:  1.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598787BDBM598787(US11613546, Example C68 | US11613546, Example C69)
Affinity DataEC50:  1.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598772BDBM598772(US11613546, Example C52)
Affinity DataEC50:  1.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598778BDBM598778(US11613546, Example C58)
Affinity DataEC50:  1.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598808BDBM598808(US11613546, Example C92)
Affinity DataEC50:  1.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598767BDBM598767(US11613546, Example C48)
Affinity DataEC50:  1.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598756BDBM598756(US11613546, Example C37 | US11613546, Example C81)
Affinity DataEC50:  1.5nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598755BDBM598755(US11613546, Example C36)
Affinity DataEC50:  1.60nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598787BDBM598787(US11613546, Example C68 | US11613546, Example C69)
Affinity DataEC50:  1.60nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

TargetEnvelope glycoprotein gp160(HIV-1)
Gilead Sciences

US Patent
LigandChemical structure of BindingDB Monomer ID 598765BDBM598765(US11613546, Example C47 | US11613546, Example C46)
Affinity DataEC50:  1.60nMAssay Description:To quantify the amount of protein binding to human serum, compounds were serially diluted (1:3) in DMSO and acoustically transferred onto 384-well as...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/10/2023
Entry Details
US Patent

Displayed 1 to 50 (of 102 total ) | Next | Last >>
Jump to: